IP Library Granted Patent US 10,377,997
Granted Patent B1
US 10,377,997 · App. 15/367,106 · Granted Aug 13, 2019

Genetically engineered

Inventors: Matthew T Weinstock (San Diego, CA); Christopher M. Wilson (San Diego, CA); Eric D. Hesek (Carlsbad, CA)
Assignee: Synthetic Genomics, Inc.
C12N9/1247C12P19/34C12P21/00C12Y207/07006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,377,997
App. No.
15/367,106
Granted
Aug 13, 2019
Kind
B1
Abstract

The present disclosure relates to the seminal discovery of a generation and use of genetically engineered Vibrio sp. Provided is the use of the genetically engineered bacteria for the construction, maintenance, manipulation, and/or propagation of DNA constructs; protein expression; protein secretion; vectors and other metabolic tools; metabolic engineering; expression of cellular extracts for cell-free biology; shuttle vectors; cloning vectors; and for synthetic biology applications. The disclosure also relates to the use of the replication machinery of Vibrio sp. as a cloning or expression vector for replication of recombinant DNA constructs. The disclosure also relates to methods of use of the above.

Claims (25)

1. A vector operable in a Vibrio sp., comprising:

a Vibrio chromosome II sequence comprising at least 90% sequence identity to SEQ ID NO: 1;

at least one selectable marker; and

a heterologous DNA sequence of greater than 10 kb.

2. The vector of claim 1 further comprising an origin of transfer.

3. The vector of claim 2 wherein the origin of transfer is oriT for RP4-mediated conjugal transfer.

4. The vector of claim 1 further comprising an origin of replication operable in a non- Vibrio and non- E. coli organism.

5. The vector of claim 1 further comprising a selectable marker operable in a yeast.

6. The vector of claim 4 further comprising an autonomously replicating sequence (ARS) and a yeast centromere sequence (CEN).

7. The vector of claim 1 where said vector replicates at a copy number of less than 10.

8. The vector of claim 7 having a copy number of less than 5.

9. The vector of claim 1 wherein the heterologous DNA sequence is greater than 50 kb.

10. A Vibrio organism comprising the vector of claim 1 .

11. A method of producing a biomolecule comprising:

a) contacting Vibrio sp. bacteria with a vector comprising a heterologous nucleic acid encoding the biomolecule and further comprising SEQ ID NO: 1 or a variant thereof, such that the heterologous nucleic acid is introduced into the bacteria;

b) growing the bacteria in a growth-conducive medium wherein the heterologous nucleic acid is expressed, thereby producing the biomolecule; and

c) isolating the biomolecule.

12. The method of claim 11 , wherein the heterologous nucleic acid is at least 10 k in size.

13. The method of claim 12 , wherein the vector further comprises an inducible promoter operably linked to the nucleic acid encoding the biomolecule.

14. The method of claim 11 , wherein the nucleic acid is introduced by conjugation, chemical competence, nature competence, or electroporation.

15. The method of claim 13 , wherein the biomolecule is a protein or peptide.

16. The method of claim 13 wherein the biomolecule is a nucleic acid.

17. The vector of claim 1 wherein the Vibrio sp. is Vibrio natriegens.

18. The vector of claim 1 comprising at least 95% sequence identity to SEQ ID NO: 1.

19. The vector of claim 17 comprising at least 95% sequence identity to SEQ ID NO: 1.

Assignments (9)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2016
From: WEINSTOCK, MATTHEW T; WILSON, CHRISTOPHER M.; HESEK, ERIC D.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 041038/0560 →
Continuity (1)
Provisional Application 62261758 · Dec 1, 2015
Cited By (4)
US 12,331,326 US 12,442,006 US 12,473,573 US 12,686,871